Joseph Lorenzo, MDProfessor of Medicine, Division of Endocrinology and Metabolism, UConn HealthDirector of Bone Biology Research, UConn Health UConn Musculoskeletal Institute
|
- Overview
- Education & Training
- Clinical Interests
- Teaching
- Committees & Organizations
- Research
- Research Opportunities
- Publications
- Presentations
Dr. Lorenzo is a professor of medicine in the Division of Endocrinology and Metabolism at UConn Health. He is a nationally renowned expert in endocrinology and metabolic bone diseases. Dr. Lorenzo's clinical interests center on the management of patients with osteoporosis and other metabolic bone disorders. He has been named a "Top Doctor in Endocrinology" by U.S. News and World Report since 2011.
Dr. Lorenzo’s research interests center on the regulation of bone remodeling by hormones and cytokines and the interaction of the immune and skeletal systems. He is a founding member of the organizing committee for a series of international conference on "Osteoimmunology: Interactions of the Immune and Skeletal Systems," which have occurred every two years since 2006 and an editor of a textbook on Osteoimmunology (editions 1 and 2). He is also an author of the chapter "Metabolic Bone Disease" in Williams Textbook of Endocrinology (editions 10, 11 and 12). Dr. Lorenzo is a former councilor of the American Society for Bone and Mineral Research, a former deputy editor of the Journal of Bone and Mineral Research and former member of the editorial board of the Journal of Clinical Investigation. He is currently the Scientific Web Page Editor for the American Society for Bone and Mineral Research and a member of the editorial board for the journal Bone.
Degree | Institution | Major |
---|---|---|
BS | Rensselaer Polytechnic Institute | Physics |
MD | State University of New York, Downstate Medical Center | Medicine |
Post-Graduate Training
Training | Institution | Specialty |
---|---|---|
Internship | University of Illinois Hospital & Clinic | Medicine |
Residency | University of Illinois Hospital & Clinic | Internal Medicine |
Fellowship | University of Connecticut School of Medicine | Endocrinology/Metabolism |
Awards
Name of Award/Honor | Awarding Organization |
---|---|
Fellow of the American Society for Bone and Mineral Research | American Society for Bone and Mineral Research |
Career Development Award, 1983-1988 | VA Research Associate |
New Investigator Research Award, 1982-1985 | NIH |
Diabetes and metabolism, endocrinology, osteoporosis, and metabolic bone disease
Lectures in the 2nd year medical and dental school course "Mechanisms of Disease" entitled "Osteoporosis and Metabolic Bone Diseases"
Name & Description | Category | Role | Type | Scope | Start Year | End Year |
---|---|---|---|---|---|---|
NIH Study Section "Skeletal Biology Development and Disease Study Section – SBDD" permanent member | Study Section | Permanent Member | External | National | 2021 | 2025 |
Scientific Web Page Editor, American Society for Bone and Mineral Research | Editorial Board | Editor | External | National | 2014 | |
Science Education Advisory Committee of the American Society for Bone and Mineral Research | Professional/Scientific Organization | Chair | External | National | 2013 | |
journal "Bone" | Editorial Board | Editorial Board | External | International | 2012 | |
Program Committee Endocrine Society | Education Committee | member | External | International | 2011 | 2012 |
Permanent member, Oral Biology and Medicine 2 NIH Study Section | Study Section | Member | External | National | 2000 | 2003 |
Institutional Animal Care and Use Committee (IACUC) | Advisory Committee | Chair | UConn Health | University | 1998 | |
Oral Biology and Medicine 2 NIH Study Section | Study Section | Ad Hoc Member | External | National | 1996 | 2000 |
Deputy Editor Journal of Bone and Mineral Research | Editorial Board | Editor | External | National | 1991 | 1995 |
Basic Science Research Interests
The influence of hormones and cytokines on both bone resorption, which is mediated by osteoclasts, and bone formation, which is mediated by osteoblasts.
The nature and regulation of osteoclast precursor cells in health and disease.
The influence of the immune system on bone remodeling.
Dr. Lorenzo’s laboratory is actively involved in research that is designed to identify the surface markers of cells that differentiate into osteoclasts in vitro and in vivo. The goal of these studies is to characterize the cells that form osteoclasts and determine if there are different between them in normal and pathologic conditions. It is hoped that this research will lead to the development of targeted therapies that selectively inhibit pathologic osteoclast formation without affecting normal bone turnover.
Clinical Research Interests
The role of hormones in the regulation of serum sclerostin.
The role of hormones in the regulation of osteoclast precursor cells.
Role of Runx1 in osteoclast biology
Journal Articles
-
PRG4 deficiency in mice alters skeletal structure, mechanics, and calvarial osteoclastogenesis, and rhPRG4 inhibits in vitro osteoclastogenesis.
Journal of orthopaedic research : official publication of the Orthopaedic Research Society 2023 Dec;
-
Sexually Dimorphic Increases in Bone Mass Following Tissue-specific Overexpression of Runx1 in Osteoclast Precursors.
Endocrinology 2022 Sep;163(9):
-
Interactions of B-lymphocytes and bone cells in health and disease.
Bone 2021 Dec;116296
-
Sexual Dimorphism in Differentiating Osteoclast Precursors Demonstrates Enhanced Inflammatory Pathway Activation in Female Cells.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2021 Feb;
-
Sexual Dimorphism in Osteoclasts.
Cells 2020 Sep;9(9):
-
Comparative transcriptomic analysis identifies distinct molecular signatures and regulatory networks of chondroclasts and osteoclasts.
Arthritis research & therapy 2020 Jul;22(1):168
-
Cytokines and Bone: Osteoimmunology.
Handbook of experimental pharmacology 2020 Feb;
-
Deletion of Wnt5a in osteoclasts results in bone loss through decreased bone formation.
Annals of the New York Academy of Sciences 2020 Jan;
-
Osteoclasts Derive Predominantly from Bone Marrow-Resident CX3CR1+ Precursor Cells in Homeostasis, whereas Circulating CX3CR1+ Cells Contribute to Osteoclast Development during Fracture Repair.
Journal of immunology (Baltimore, Md. : 1950) 2020 Jan;
-
Deletion of Runx1 in osteoclasts impairs murine fracture healing through progressive woven bone loss and delayed cartilage remodeling.
Journal of orthopaedic research : official publication of the Orthopaedic Research Society 2019 Nov;
-
Protease-Activated Receptor 1 Deletion Causes Enhanced Osteoclastogenesis in Response to Inflammatory Signals through a Notch2-Dependent Mechanism.
Journal of Immunology (Baltimore, Md. : 1950) 2019 Jul;203(1):105-116
-
PI3K activation increases SDF-1 production and number of osteoclast precursors, and enhances SDF-1-mediated osteoclast precursor migration.
Bone reports 2019 Jun;10100203
-
Continuous PTH in Male Mice Causes Bone Loss Because It Induces Serum Amyloid A (SAA).
Endocrinology 2018 May;1592759-2776
-
Osteoclast-secreted SLIT3 coordinates bone resorption and formation.
The Journal of clinical investigation 2018 Apr;128(4):1429-1441
-
Dried plum alleviates symptoms of inflammatory arthritis in TNF transgenic mice.
The Journal of nutritional biochemistry 2017 Oct;5254-61
-
Runx1 regulates myeloid precursor differentiation into osteoclasts without affecting differentiation into antigen presenting or phagocytic cells in both males and females.
Endocrinology 2016 Jun;1573058-69
-
Serum Amyloid A3 Secreted by Preosteoclasts Inhibits Parathyroid Hormone-Stimulated cAMP Signaling in Murine Osteoblasts.
The Journal of biological chemistry 2015 Dec;2913882-94
-
Loss of Cbl-PI3K interaction in mice prevents significant bone loss following ovariectomy.
Bone 2014 Jul;671-9
-
Runx1-mediated regulation of osteoclast differentiation and function.
Molecular endocrinology (Baltimore, Md.) 2014 Apr;28(4):546-53
-
Altered hematopoietic stem cell and osteoclast precursor frequency in cathepsin K null mice.
Journal of cellular biochemistry 2014 Mar;115(8):1449-57
-
Loss of Cbl-PI3K interaction enhances osteoclast survival due to p21-Ras mediated PI3K activation independent of Cbl-b.
Journal of cellular biochemistry 2014 Jan;115(7):1277-89
-
Identification, characterization, and isolation of a common progenitor for osteoclasts, macrophages, and dendritic cells from murine bone marrow and periphery.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2013 May;28(5):1203-13
-
Changes in bone sclerostin levels in mice after ovariectomy vary independently of changes in serum sclerostin levels.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2013 Mar;28(3):618-26
-
Negative regulation of osteoclast precursor differentiation by CD11b and β2 integrin-B-cell lymphoma 6 signaling.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2013 Jan;28(1):135-49
-
Osteoblast-specific overexpression of human interleukin-7 rescues the bone mass phenotype of interleukin-7-deficient female mice.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2012 May;27(5):1030-42
-
Long-term treatment with raloxifene, but not bisphosphonates, reduces circulating sclerostin levels in postmenopausal women.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2012 Apr;23(4):1235-43
-
Parathyroid hormone regulates the distribution and osteoclastogenic potential of hematopoietic progenitors in the bone marrow.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2011 Jun;26(6):1207-16
-
How B cells influence bone biology in health and disease.
Bone 2010 Sep;47(3):472-9
-
Immature osteoblast lineage cells increase osteoclastogenesis in osteogenesis imperfecta murine.
The American journal of pathology 2010 May;176(5):2405-13
-
Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women.
The Journal of clinical endocrinology and metabolism 2010 Apr;95(4):1991-7
-
Nuclear isoforms of fibroblast growth factor 2 are novel inducers of hypophosphatemia via modulation of FGF23 and KLOTHO.
The Journal of biological chemistry 2010 Jan;285(4):2834-46
-
Ebf1-dependent control of the osteoblast and adipocyte lineages.
Bone 2009 Apr;44(4):537-46
-
Accentuated osteoclastic response to parathyroid hormone undermines bone mass acquisition in osteonectin-null mice.
Bone 2008 Aug;43(2):264-73
-
Estradiol rapidly inhibits osteoclastogenesis and RANKL expression in bone marrow cultures in postmenopausal women: a pilot study.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2008 Feb;19(2):193-9
-
v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation.
Nature medicine 2006 Dec;12(12):1403-9
-
Megakaryocyte-mediated inhibition of osteoclast development.
Bone 2006 Nov;39(5):991-9
-
T lymphocyte-deficient mice lose trabecular bone mass with ovariectomy.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2006 Nov;21(11):1704-12
-
Congenic mice provide in vivo evidence for a genetic locus that modulates serum insulin-like growth factor-I and bone acquisition.
Endocrinology 2006 Aug;147(8):3915-23
-
Interleukin-7 influences osteoclast function in vivo but is not a critical factor in ovariectomy-induced bone loss.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2006 May;21(5):695-702
-
RANKL-stimulated osteoclast-like cell formation in vitro is partially dependent on endogenous interleukin-1 production.
Bone 2006 May;38(5):678-85
-
Identification of multiple osteoclast precursor populations in murine bone marrow.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2006 Jan;21(1):67-77
-
Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis.
The Journal of experimental medicine 2005 Sep;202(5):589-95
-
Biphasic effect of prostaglandin E2 on osteoclast formation in spleen cell cultures: role of the EP2 receptor.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2005 Jan;20(1):23-9
-
Pax5-deficient mice exhibit early onset osteopenia with increased osteoclast progenitors.
Journal of immunology (Baltimore, Md. : 1950) 2004 Dec;173(11):6583-91
-
Hematopoiesis is severely altered in mice with an induced osteoblast deficiency.
Blood 2004 May;103(9):3258-64
-
Megakaryocyte-osteoblast interaction revealed in mice deficient in transcription factors GATA-1 and NF-E2.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2004 Apr;19(4):652-60
-
Interleukin-7 is a direct inhibitor of in vitro osteoclastogenesis.
Endocrinology 2003 Aug;144(8):3524-31
-
Impaired osteoclast formation in bone marrow cultures of Fgf2 null mice in response to parathyroid hormone.
The Journal of biological chemistry 2003 Jun;278(23):21258-66
-
The surface antigen CD45R identifies a population of estrogen-regulated murine marrow cells that contain osteoclast precursors.
Bone 2003 Jun;32(6):581-90
-
Increased bone mass is a part of the generalized lymphoproliferative disorder phenotype in the mouse.
Journal of immunology (Baltimore, Md. : 1950) 2003 Feb;170(3):1540-7
-
Characterization of osteoclast precursor cells in murine bone marrow
Journal of Musculoskeletal Neuronal Interactions 2003 Jan;3(4):273-277
-
1,25(OH)2 vitamin D3-stimulated osteoclast formation in spleen-osteoblast cocultures is mediated in part by enhanced IL-1 alpha and receptor activator of NF-kappa B ligand production in osteoblasts.
Journal of immunology (Baltimore, Md. : 1950) 2002 Sep;169(5):2374-80
-
Role of B lymphocytes in new bone formation.
Laboratory investigation; a journal of technical methods and pathology 2000 Nov;80(11):1761-74
-
Prostaglandin G/H synthase-2 is required for maximal formation of osteoclast-like cells in culture.
The Journal of clinical investigation 2000 Mar;105(6):823-32
-
Prostaglandin G/H synthase-2 is required for maximal stimulation of osteoclast-like cell formation in murine marrow and spleen cultures.
J Clin Invest 2000 Jan;105823-832
-
Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation.
Endocrinology 1999 Aug;140(8):3552-61
-
Osteoclasts and effects of interleukin 4 in development of chronic osteomyelitis.
Clinical orthopaedics and related research 1998 Oct;(355):290-9
-
Parathyroid hormone induces interleukin-6 heterogeneous nuclear and messenger RNA expression in murine calvarial organ cultures.
Bone 1998 Oct;23(4):327-32
-
Mice lacking the type I interleukin-1 receptor do not lose bone mass after ovariectomy.
Endocrinology 1998 Jun;139(6):3022-5
-
Basic fibroblast growth factor induces osteoclast formation in murine bone marrow cultures.
Bone 1998 Apr;22(4):309-16
-
Lack of evidence for an increase in interleukin-6 expression in adult murine bone, bone marrow, and marrow stromal cell cultures after ovariectomy.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1996 Dec;11(12):1926-34
-
Interleukin-6 expression and histomorphometry of bones from mice deficient in receptors for interleukin-1 or tumor necrosis factor.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1996 Nov;11(11):1736-44
-
Regulation of NFIL-6 and IL-6 expression by basic fibroblast growth factor in osteoblasts.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1996 Jun;11(6):760-7
-
Oncostatin-M: a new bone active cytokine that activates osteoblasts and inhibits bone resorption.
Endocrinology 1996 Apr;137(4):1151-8
-
Expression of the calcitonin receptor in bone marrow cell cultures and in bone: a specific marker of the differentiated osteoclast that is regulated by calcitonin.
Endocrinology 1995 Oct;136(10):4572-81
-
Ovariectomy enhances and estrogen replacement inhibits the activity of bone marrow factors that stimulate prostaglandin production in cultured mouse calvariae.
The Journal of clinical investigation 1995 Jul;96(1):539-48
-
Expression of monocyte chemoattractant protein 1 in human osteoblastic cells stimulated by proinflammatory mediators.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1994 Jul;9(7):1123-30
-
Stimulation of prostaglandin E2 production by interleukin-1 alpha and transforming growth factor alpha in osteoblastic MC3T3-E1 cells.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1994 Jun;9(6):817-23
-
Expression and regulation of basic fibroblast growth factor mRNA levels in mouse osteoblastic MC3T3-E1 cells.
The Journal of biological chemistry 1994 Mar;269(12):9392-6
-
Production of both 92 and 72 kDa gelatinases by bone cells.
Matrix 1992 Jan;12282-290
-
A human periodontal ligament fibroblast clone releases a bone resorption inhibition factor in vitro.
Journal of dental research 1991 Feb;70(2):99-101
-
Leukemia inhibitory factor (LIF) inhibits basal bone resorption in fetal rat long bone cultures.
Cytokine 1990 Jul;2(4):266-71
-
Interleukin-1 alpha and phorbol ester inhibit collagen synthesis in osteoblastic MC3T3-E1 cells by a transcriptional mechanism.
Molecular endocrinology (Baltimore, Md.) 1990 Feb;4(2):184-90
-
The effects of thionapthene-2-carboxylic acid-lysine on the hypercalcemia of malignancy in the rat.
Calcified tissue international 1989 Jan;44(1):61-4
-
DNA synthesis is not necessary for osteoclastic responses to parathyroid hormone in cultured fetal rat long bones.
The Journal of clinical investigation 1983 Dec;72(6):1924-9
-
Divalent cation ionophores stimulate resorption and inhibit DNA synthesis in cultured fetal rat bone.
Science (New York, N.Y.) 1981 Jun;212(4499):1157-9
-
The ability of chemotactic factors to induce lysosomal enzyme release. II. The mechanism of release.
Journal of immunology (Baltimore, Md. : 1950) 1974 Jun;112(6):2055-62
Book Chapters
-
Cytokines and the Pathogenesis of Osteoporosis
Osteoporosis 2018 Dec;
-
B cells in the Regulation of Bone Metabolism
Encyclopedia of Bone Biology 2018 Jun;
-
Local Regulators of Bone
Interleukin-1, Tumor Necrosis Factor, Interferons, the IL-6 Family, and Additional Cytokines
Principles of Bone Biology 2018 Jun;
-
Local Regulators of Bone
Interleukin-1, Tumor Necrosis Factor, Interferons, the IL-6 Family, and Additional Cytokines
Principals of Bone Biology
-
Local Regulators of Bone
Interleukin-1, Tumor Necrosis Factor, Interferons, the IL-6 Family, and Additional Cytokines
Principals of Bone Biology
-
Local Regulators of Bone: Interleukin-1, Tumor Necrosis Factor, Interferons, the IL-6 Family, and Additional Cytokines
Principals of Bone Biology
-
Local Regulators of Bone: Interleukin-1, Tumor Necrosis Factor, Interferons, the IL-6 Family, and Additional Cytokines
Principals of Bone Biology
Abstracts
-
Effect of exogenous and endogenous prostaglandin E2 on osteoclastogenesis in the RAW 264.7 macrophage cell line.
J Bone Miner Res 2004 Jan;19(S1)S409
-
Prostaglandin E2 stimulation of osteoclast formation in hematopoietic cell cultures is mediated by a soluble T cell factor.
J Bone Miner Res 2003 Jan;18(S2)S236
-
Effects of aging on the regulation of osteoclast formation in murine bone marrow cultures.
J Bone Miner Res 2000 Jan;15(S1)S237
-
IL-1 regulation of osteoblastic differentiation in murine bone marrow and primary osteoblastic cultures.
J Bone Miner Res 2000 Jan;15(S1)S508
-
Effects of prostaglandin G/H synthase-2 knockout on bone.
J Bone Miner Res 1999 Jan;14(S1)S172
-
Osteoblasts from interleukin 1 receptor type 1 knockout mice have a markedly reduced capacity to support osteoclast function.
J Bone Miner Res 1999 Jan;14(S1)S164
-
Decreased osteoclastogenic responses in marrow cultures from mice with disruption of the PGHS-2 gene.
J Bone Miner Res 1998 Jan;13(S1)S330
-
Downregulation of mRNA expression for the "decoy" interleukin-1 receptor 2 by ovariectomy in mice.
J Bone Min Res 1997 Jan;12(S1)S433
-
Increased production of inflammatory mediators immed-iately after surgery by marrow stromal cell cultures from sham operated and ovariectomized mice.
J Bone Min Res 1995 Jan;10(S1)S346
-
Ovariectomy or estrogen treatment do not alter interleukin 6 mRNA expression in adult murine bone and bone marrow.
J Bone Min Res 1994 Jan;9(S1)S389
Conference Papers
-
B lymphocytes and the skeleton.
Annals of the New York Academy of Sciences 2007 Nov;111782-93
-
Immunologic regulation of bone development.
Advances in experimental medicine and biology 2007 Jan;60247-56
-
Osteoclast precursor cells.
Advances in experimental medicine and biology 2007 Jan;60277-82
Editorials
-
Osteoimmunology.
Immunological reviews 2005 Dec;2085-6
Letters
-
Bone mineral screening for osteoporosis.
The New England journal of medicine 1987 Jul;317(5):315-6
Notes
-
Ephs and ephrins: a new way for bone cells to communicate.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2008 Aug;23(8):1168-9
-
Interactions between immune and bone cells: new insights with many remaining questions.
The Journal of clinical investigation 2000 Sep;106(6):749-52
Other
-
Epidermal growth factor stimulates prostaglandin synthesis in fetal rat bone cultures when DNA synthesis is inhibited
Clinical Research 1982 Jan;30(2):
-
The effect of forskolin, an activator of adenylate cyclase, on bone resorption in organ culture
Calcified Tissue International 1982 Jan;34(Suppl. 1):
-
Inhibition of DNA synthesis in bone organ culture does not affect parathyroid hormone stimulated resorption
Calcified Tissue International 1981 Jan;33(3):296
Reviews
-
Osteoclasts: Other functions.
Bone 2022 Dec;165116576
-
Osteoimmunology: interactions of the bone and immune system.
Endocrine reviews 2008 Jun;29(4):403-40
-
Cytokines regulating osteoclast formation and function.
Current opinion in rheumatology 2006 Jul;18(4):411-8
-
Osteoimmunology: interplay between the immune system and bone metabolism.
Annual review of immunology 2006 Jan;2433-63
-
Role of endocrine-immune dysregulation in osteoporosis, sarcopenia, frailty and fracture risk.
Molecular aspects of medicine 2005 Jun;26(3):181-201
-
The origins of osteoclasts.
Current opinion in rheumatology 2004 Jul;16(4):464-8
-
A new hypothesis for how sex steroid hormones regulate bone mass.
The Journal of clinical investigation 2003 Jun;111(11):1641-3
Short Surveys
-
Osteoimmunology: cytokines and the skeletal system.
BMB reports 2008 Jul;41(7):495-510
Title or Abstract | Type | Sponsor/Event | Date/Year | Location |
---|---|---|---|---|
Studies of Osteoclast Development | Lecture | *th International Conference on Osteoimmunology | 2022 | Crete, Greece |
Vitamin D | Lecture | Department of Medicine UConn Health | 2020 | UConn Health Low Lecture Hall |
Origins of the Osteoclast and the Role of Protease Activated Receptor 1 in Regulating Inflammation in Bone | Lecture | Pharmacology and Toxicology Seminar Series, Jacobs School of Medicine | 2019 | Jacobs School of Medicine and Biomedical Sciences Buffalo |
Vitamin D: hope, hype and truth | Lecture | UConn Health 23rd Annual Diabetes and Endocrinology Seminar | 2019 | Red Lion Hotel, Cromwell, CT |